PTK2 and melanoma: Our in vitro results using pancreatic cancer cells are similar to a previously published report [20], where SDC-2 induced the migratory activity of melanoma cells through activation of FAK, which directly and indirectly interacts not only with MAPK and Src signaling, but also with CDC42, Cortactin and WAVE.